2023
POSSIBLE EFFECT OF OAS1 AND TMPRSS6 BUT NOT DPP4 AND ZNF335 POLYMORPHISMS ON COVID-19 SEVERITY IN THE CZECH POPULATION
HUBACEK, Jaroslav A, Tom PHILIPP, Vera ADAMKOVA, Ondřej MÁJEK, Dana DLOUHA et. al.Základní údaje
Originální název
POSSIBLE EFFECT OF OAS1 AND TMPRSS6 BUT NOT DPP4 AND ZNF335 POLYMORPHISMS ON COVID-19 SEVERITY IN THE CZECH POPULATION
Autoři
HUBACEK, Jaroslav A (203 Česká republika), Tom PHILIPP (203 Česká republika), Vera ADAMKOVA (203 Česká republika), Ondřej MÁJEK (203 Česká republika, domácí), Dana DLOUHA (203 Česká republika) a Ladislav DUŠEK (203 Česká republika, domácí)
Vydání
Central European journal of public health, Praha, Česká lékařská společnost J.E. Purkyně, 2023, 1210-7778
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.200 v roce 2022
Kód RIV
RIV/00216224:14110/23:00133875
Organizační jednotka
Lékařská fakulta
UT WoS
001166654700002
Klíčová slova anglicky
COVID-19; DPP4; OAS1; polymorphism; SARS-CoV-2; severity; TMPRSS6; ZNF335
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 22. 3. 2024 09:34, Mgr. Tereza Miškechová
Anotace
V originále
Objectives: The acute respiratory syndrome, known as COVID-19, is characterised by high morbidity and increased mortality. Genetic factors may partially explain the differences in susceptibility to and severity of COVID-19. Methods: We have analysed common functional polymorphisms within the OAS1 (rs4767027), TMPRSS6 (rs855791), DPP4 (rs3788979), and ZNF335 (rs3848719) genes in SARS-CoV-2 positive subjects (n = 521, different disease severity) and in population controls (n = 2,559 subjects, COVID-19 status unknown). Results: Neither DPP4 nor ZNF335 were associated with disease susceptibility or severity in the Czech population in any of the models used for calculation. T allele carriers of the OAS1 polymorphism seem to be protective against symptomatic COVID-19 (p = 0.002 calculated for trend; asymptomatic, symptomatic, hospitalised). Similarly, within the TMPRSS6, minor TT homozygotes associated with lower plasma Fe concentrations were underrepresented in the overall patient group (p = 0.044; OR = 0.77, 95% CI: 0.59-0.99), and the difference was mainly driven by the severe COVID-19 subjects. In general, risky homozygotes of these two polymorphisms were less frequent than expected in the group of hospitalised COVID-19 survivors. Conclusions: Common variants within OAS1 (rs4767027) and TMPRSS6 (rs855791) play some role in COVID-19 pathology in the Czech Caucasian population. Whether the depletion of minor allele carriers of these two variants is associated with increased COVID-19 mortality, needs to be analysed in an external confirmatory study.